The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of lenalidomide combined with R-CHOP (R2CHOP) on negative prognostic impact of nongerminal center (non-GCB) phenotype in newly diagnosed diffuse large B-cell lymphoma: A phase 2 study.
Grzegorz S. Nowakowski
No relevant relationships to disclose
Betsy LaPlant
No relevant relationships to disclose
William R Macon
No relevant relationships to disclose
Craig B. Reeder
Research Funding - Celgene
James M. Foran
No relevant relationships to disclose
Garth D. Nelson
No relevant relationships to disclose
Carrie A. Thompson
No relevant relationships to disclose
Candido Rivera
No relevant relationships to disclose
David James Inwards
No relevant relationships to disclose
Ivana N. M. Micallef
No relevant relationships to disclose
Patrick B. Johnston
No relevant relationships to disclose
Luis F. Porrata
No relevant relationships to disclose
Stephen Maxted Ansell
No relevant relationships to disclose
Thomas Matthew Habermann
No relevant relationships to disclose
Thomas E. Witzig
No relevant relationships to disclose